SCHEMBL12220409

SCHEMBL12220409

CC(=O)NC1=CC(=C(C)C)C(NC(C)=O)=CC1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.45
S100A4 P26447 1/20 0.41
GAA P10253 3/20 0.38
HSD17B10 Q99714 2/20 0.38
PKM P14618 1/20 0.38
ALOX15 P16050 1/20 0.38
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
LMNA P02545 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.33
HTT P42858 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NAPRT Q6XQN6 1/20 0.33
ALDH1A1 P00352 3/20 0.32
CA12 O43570 1/20 0.32
BRD4 O60885 1/20 0.32
NR1I2 O75469 1/20 0.32
CA1 P00915 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12242131 0.78 TDP1 (0.46) TDP1S100A4GAAHSD17B10PKM
SCHEMBL28654605 0.78 TDP1 (0.46) TDP1S100A4GAAHSD17B10PKM
SCHEMBL11281004 0.76 TDP1 (0.45) TDP1S100A4GAAHSD17B10PKM
SCHEMBL7898541 0.73 HSP90AA1 (0.45) TDP1S100A4HSD17B10ALOX15MEN1
SCHEMBL28929832 0.73 TDP1 (0.42) TDP1S100A4GAAHSD17B10PKM
SCHEMBL1603211 0.71 TDP1 (0.43) TDP1S100A4GAAHSD17B10PKM
SCHEMBL11240568 0.69 TDP1 (0.39) TDP1S100A4GAAHSD17B10PKM
SCHEMBL11700504 0.67 TDP1 (0.37) TDP1S100A4GAAHSD17B10ALOX15
SCHEMBL11252306 0.67 TDP1 (0.40) TDP1S100A4GAAHSD17B10PKM
SCHEMBL14386783 0.64 TDP1 (0.49) TDP1S100A4GAAPKMMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8039532-B2 Heterocyclic compound, ultraviolet absorbent and composition containing the same FUJIFILM CORPORATION (JP) 2011-10-18 US disclosed
US-20100210762-A1 HETEROCYCLIC COMPOUND, ULTRAVIOLET ABSORBENT AND COMPOSITION CONTAINING THE SAME FUJIFILM CORPORATION (JP) 2010-08-19 US disclosed
US-20090240067-A1 METHOD OF PRODUCING A BISBENZODITHIOL COMPOUND FUJIFILM CORPORATION (JP) 2009-09-24 US disclosed
US-20090240067-A1 METHOD OF PRODUCING A BISBENZODITHIOL COMPOUND FUJIFILM CORPORATION (JP) 2009-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100210762-A1 HETEROCYCLIC COMPOUND, ULTRAVIOLET ABSORBENT AND COMPOSITION CONTAINING THE SAME F12, F2, CYP24A1 TDP1 1400/4885S100A4 390/4885GAA 4733/4885
US-20090240067-A1 METHOD OF PRODUCING A BISBENZODITHIOL COMPOUND SQOR, NQO1, PBRM1 TDP1 2486/4885S100A4 1387/4885GAA 3775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.